Condition: Safety · Tolerability · GenSci098 · Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
To evaluate the safety and tolerability of single and multiple ascending subcutaneous doses of GenSci098 in patients with thyroid eye disease (TED)
This description comes directly from the study's public registry record.
Jun Yan · +8615800359085 · yanjun01@genscigroup.com
Always discuss trial participation with your own doctor first.
| Shanghai Ninth People's hospital, Shanghai Jiaotong University School of Medication | Shanghai, Shanghai Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06569758